In vivo MRI for effective non-invasive detection and follow-up of an orthotopic mouse model of lung cancer

NMR in Biomedicine

Volumn 27, Issue 8, 2014, Pages 971-979

  Bianchi, Andrea ^a   Dufort, Sandrine ^b,c,d   Fortin, Pierre Yves ^a   Lux, François ^e   Raffard, Gérard ^a   Tassali, Nawal ^a   Tillement, Olivier ^e   Coll, Jean Luc ^c,d   Crémillieux, Yannick ^a  

^a CNRS University Bordeaux Segalen   (France)

^b Nano HSAS   (France)

^c INSTITUT ALBERT BONNIOT   (France)

^d UNIV GRENOBLE ALPES   (France)

^e UNIVERSITÉ LYON 1   (France)

Author keywords

Bioluminescence imaging; Lung cancer; Lung MRI; MRI; Orthotopic adenocarcinoma model

Indexed keywords

BIOLOGICAL ORGANS; BIOLUMINESCENCE; DIAGNOSIS; DISEASES; IONIZING RADIATION; MAMMALS; PHOSPHORESCENCE; TUMORS;

BIOLUMINESCENCE IMAGING; HISTOLOGICAL ANALYSIS; LUNG CANCER; LUNG MRIS; NON SMALL CELL LUNG CANCER; NON-INVASIVE DETECTION; ORTHOTOPIC; QUANTITATIVE DETECTION;

MAGNETIC RESONANCE IMAGING;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOLUMINESCENCE; CANCER LOCALIZATION; CANCER SIZE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; FEMALE; FOLLOW UP; FREE BREATHING GRADIENT ECHO LUNG MAGNETIC RESONANCE IMAGING; HISTOPATHOLOGY; IN VIVO STUDY; LUNG ADENOCARCINOMA; MOUSE; NON INVASIVE MEASUREMENT; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROMETER; PRIORITY JOURNAL; RESPIRATORY GATED GRADIENT ECHO LUNG MAGNETIC RESONANCE IMAGING; RESPIRATORY GATED IMAGING; ULTRA SHORT ECHO FREE BREATHING TIME MAGNETIC RESONANCE IMAGING; ANIMAL; DRUG SCREENING; HUMAN; LUMINESCENCE; LUNG NEOPLASMS; NUDE MOUSE; SIGNAL NOISE RATIO; TIME; TUMOR CELL LINE;

MUS;

ANIMALS; CELL LINE, TUMOR; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUMINESCENT MEASUREMENTS; LUNG NEOPLASMS; MAGNETIC RESONANCE IMAGING; MICE, NUDE; SIGNAL-TO-NOISE RATIO; TIME FACTORS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84904790216     PISSN: 09523480     EISSN: 10991492     Source Type: Journal    
DOI: 10.1002/nbm.3142     Document Type: Article

References (33)

1. Parkin M, Tyczynski JE, Boffetta P, Samet J, Shields P, Caporaso N. Lung cancer epidemiology and etiology. Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart, 3rd edn, Travis WD, Brambilla E, Müller-Hermelink HK, Harris CC (eds). WHO Press: Geneva, 2004, pp. 12-15.
2. Molina JR, Yang P, Cassivi SD, Schild SE, Adjei AA. Non-small cell lung cancer: Epidemiology, risk factors, treatment, and survivorship. Mayo Clin. Proc. 2008; 83: 584-594.
3. Koyama H, Ohno Y, Seki S, Nishio M, Yoshikawa T, Matsumoto S, Sugimura K. Magnetic resonance imaging for lung cancer. J. Thorac. Imaging 2013; 28: 138-150.
4. Herbst RS, Heymach JV, Lippman SM. Lung cancer. N. Engl. J. Med. 2008; 359: 1367-1380.
5. Buccheri G, Ferrigno D. Lung cancer: clinical presentation and specialist referral time. Eur. Respir. J. 2004; 24: 894-904.
6. Gohagan J, Marcus P, Fagerstrom R, Pinsky P, Kramer B, Prorok P, Writing Committee, Lung Screening Study Research Group. Baseline findings of a randomized feasibility trial of lung cancer screening with spiral CT scan vs chest radiograph: the lung screening study of the National Cancer Institute. Chest 2004; 126: 114-121.
7. Gohagan J, Marcus P, Fagerstrom R, Pinsky P, Kramer B, Prorok P, Ascher S, Bailey W, Brewer B, Church T, Engelhard D, Ford M, Fouad M, Freedman M, Gelmann E, Gierada D, Hocking W, Inampudi S, Irons B, Johnson CC, Jones A, Kucera G, Kvale P, Lappe K, Manor W, Moore A, Nath H, Neff S, Oken M, Plunkett M, Price H, Reding D, Riley T, Schwartz M, Spizarny D, Yoffie R, Zylak C, Lung Screening Study Research Group. Final results of the Lung Screening Study, a randomized feasibility study of spiral CT versus chest X-ray screening for lung cancer. Lung Cancer 2005; 47: 9-15.
8. International Early Lung Cancer Action Program Investigators, Henschke CI, Yankelevitz DF, Libby DM, Pasmantier MW, Smith JP, Miettinen OS. Survival of patients with stage I lung cancer detected on CT screening. N. Engl. J. Med. 2006; 355: 1763-1771.
9. Brenner DJ, Hall EJ. Computed tomography: an increasing source of radiation exposure. N. Engl. J. Med. 2007; 357: 2277-2284.
10. US Preventive Services Task Force. Lung cancer screening: recommendation statement. Ann. Intern. Med. 2004; 140: 738-739.
11. Smith R, von Eschenbach A, Wender R, Levin B, Byers T, Rothenberger D, Brooks D, Creasman W, Cohen C, Runowicz C, Saslow D, Cokkinides V, Eyre H, ACS Prostate Cancer Advisory Committee, ACS Colorectal Cancer Advisory Committee, ACS Endometrial Cancer Advisory Committee. American Cancer Society guidelines for the early detection of cancer: update of early detection guidelines for prostate, colorectal, and endometrial cancers: also: update 2001 - testing for early lung cancer detection. CA Cancer J. Clin. 2001; 51: 38-75.
12. Biederer J, Beer M, Hirsch W, Wild J, Fabel M, Puderbach M, Van Beek EJ. MRI of the lung (2/3). Why...when...how? Insights Imaging 2012; 3: 355-371.
13. Hedlund L, Dewalt S, Cofer G, Johnson G. MR microscopy of the lung. Application of magnetic resonance to the study of the lung, Cutillo A (ed.). Futura Press: Armonk, NY, 1996, pp. 401-415.
14. Beckmann N, Cannet C, Karmouty-Quintana H, Tigani B, Zurbruegg S, Blé F-X, Crémillieux Y, Trifilieff A. Lung MRI for experimental drug research. Eur. J. Rad. 2007; 64: 381-396.
15. Garbow JR, Zhang Z, You M. Detection of primary lung tumors in rodents by magnetic resonance imaging. Cancer Res. 2004; 64: 2740-2742.
16. Garbow JR, Wang M, Wang Y, Lubet RA, You M. Quantitative monitoring of adenocarcinoma development in rodents by magnetic resonance imaging. Clin. Cancer Res. 2008; 14: 1363-1367.
17. Glover GH, Pauly JM. Projection Reconstruction Techniques for Reduction of Motion Effects in MRI. Magn. Reson. Med. 1992; 28: 275-289.
18. Bernstein MA, King KF, Zhou XJ. Basics of physiologic gating, triggering, and monitoring. Handbook of MRI Pulse Sequences, Bernstein MA, King KF, Zhou XJ (eds). Elsevier Academic Press: Waltham, MA, 2004, pp. 443-490.
19. Beckmann N, Tigani B, Mazzoni L, Fozard JR. MRI of lung parenchyma in rats and mice using a gradient-echo sequence. NMR Biomed. 2001; 14: 297-306.
20. Wild JM, Marshall H, Bock M, Schad LR, Jakob PM, Puderbach M, Molinari F, Van Beek EJ, Biederer J. MRI of the lung (1/3): methods. Insights Imaging 2012; 3: 345-353.
21. Bergin CJ, Pauly JM, Macovski A. Lung parenchyma: projection reconstruction MR imaging. Radiology 1991; 179: 777-781.
22. Bergin CJ, Noll DC, Pauly JM, Glover GH, Macovski A. MR imaging of lung parenchyma: a solution to susceptibility. Radiology 1992; 183: 673-676.
23. Zurek M, Bessaad A, Cieslar K, Crémillieux Y. Validation of simple and robust protocols for high-resolution lung proton MRI in mice. Magn. Reson. Med. 2010; 64: 401-407.
24. Bianchi A, Ozier A, Ousova O, Raffard G, Crémillieux Y. Ultrashort-TE MRI longitudinal study and characterization of a chronic model of asthma in mice: inflammation and bronchial remodeling assessment. NMR Biomed. 2013; 26: 1451-1459.
25. Johnson KM, Fain SB, Schiebler ML, Nagle S. Optimized 3D ultrashort echo time pulmonary MRI. Magn. Reson. Med. 2013; 70: 1241-1250.
26. Lederlin M, Crémillieux Y. Three-Dimensional Assessment of Lung Tissue Density Using a Clinical Ultrashort Echo Time at 3 Tesla: A Feasibility Study in Healthy Subjects. J. Magn. Reson. Imaging. In press, DOI: 10.1002/jmri.24429.
27. Beckmann N, Tigani B, Ekatodramis D, Borer R, Mazzoni L, Fozard JR. Pulmonary edema induced by allergen challenge in the rat: noninvasive assessment by magnetic resonance imaging. Magn. Reson. Med. 2001; 45: 88-95.
28. Keramidas M, Josserand V, Righini CA, Wenk C, Faure C, Coll JL. Intraoperative near-infrared image-guided surgery for peritoneal carcinomatosis in a preclinical experimental model. Br. J. Surg. 2010; 97(5): 737-743.
29. Rehemtulla A, Stegman LD, Cardozo SJ, Gupta S, Hall DE, Contag CH, Ross BD. Rapid and quantitative assessment of cancer treatment response using in vivo bioluminescence imaging. Neoplasia 2000; 2: 491-495.
30. Kuo TH, Kubota T, Watanabe M, Furukawa T, Kase S, Tanino H, Saikawa Y, Ishibiki K, Kitajima M, Hoffman RM. Site-specific hemosensitivity of human small-cell lung carcinoma growing orthotopically compared to subcutaneously in SCID mice: the importance of orthotopic models to obtain relevant drug evaluation data. Anticancer Res 1993; 13: 627-630.
31. Söling A, Rainov NG. Bioluminescence imaging in vivo - application to cancer research. Expert Opin. Biol. Ther. 2003; 3: 1163-1172.
32. Dhermain FG, Hau P, Lanfermann H, Jacobs AH, van den Bent M. Advanced MRI and PET imaging for assessment of treatment response in patients with gliomas. Lancet Neurol. 2010; 9: 906-920.
33. Kalber TL, Campbell-Washburn AE, Siow BM, Sage E, Price AN, Ordidge KL, Walker-Samuel S, Janes SM, Lythgoe MF. Primed infusion with delayed equilibrium of Gd.DTPA for enhanced imaging of small pulmonary metastases. PLoS One 2013; 8: e54903.